682 related articles for article (PubMed ID: 32160394)
1. miR-29c-3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease.
Wang R; Li Q; He Y; Yang Y; Ma Q; Li C
Genes Cells; 2020 Jun; 25(6):364-374. PubMed ID: 32160394
[TBL] [Abstract][Full Text] [Related]
2. miR-99b-3p/Mmp13 axis regulates NLRP3 inflammasome-dependent microglial pyroptosis and alleviates neuropathic pain via the promotion of autophagy.
Gao X; Gao LF; Zhang ZY; Jia S; Meng CY
Int Immunopharmacol; 2024 Jan; 126():111331. PubMed ID: 38061116
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.
Sun Q; Wang S; Chen J; Cai H; Huang W; Zhang Y; Wang L; Xing Y
J Cell Physiol; 2019 Dec; 234(12):23379-23387. PubMed ID: 31232472
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA X-Inactive-Specific Transcript Promotes the Secretion of Inflammatory Cytokines in LPS Stimulated Astrocyte Cell Via Sponging miR-29c-3p and Regulating Nuclear Factor of Activated T cell 5 Expression.
Zhang M; Yang H; Chen Z; Hu X; Wu T; Liu W
Front Endocrinol (Lausanne); 2021; 12():573143. PubMed ID: 33776905
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA GAS5 promotes microglial inflammatory response in Parkinson's disease by regulating NLRP3 pathway through sponging miR-223-3p.
Xu W; Zhang L; Geng Y; Liu Y; Zhang N
Int Immunopharmacol; 2020 Aug; 85():106614. PubMed ID: 32470877
[TBL] [Abstract][Full Text] [Related]
6. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
[TBL] [Abstract][Full Text] [Related]
8. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
[TBL] [Abstract][Full Text] [Related]
9. TREM2 Deficiency Aggravates NLRP3 Inflammasome Activation and Pyroptosis in MPTP-Induced Parkinson's Disease Mice and LPS-Induced BV2 Cells.
Huang P; Zhang Z; Zhang P; Feng J; Xie J; Zheng Y; Liang X; Zhu B; Chen Z; Feng S; Wang L; Lu J; Liu Y; Zhang Y
Mol Neurobiol; 2024 May; 61(5):2590-2605. PubMed ID: 37917301
[TBL] [Abstract][Full Text] [Related]
10. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
11. Involvement of NLRP3 inflammasome in methamphetamine-induced microglial activation through miR-143/PUMA axis.
Du L; Shen K; Bai Y; Chao J; Hu G; Zhang Y; Yao H
Toxicol Lett; 2019 Feb; 301():53-63. PubMed ID: 30394308
[TBL] [Abstract][Full Text] [Related]
12. Baohuoside I suppresses the NLRP3 inflammasome activation via targeting GPER to fight against Parkinson's disease.
Gu Y; Hu ZF; Zheng DW; Yang YQ; Dong XL; Chen WF
Phytomedicine; 2024 Apr; 126():155435. PubMed ID: 38394727
[TBL] [Abstract][Full Text] [Related]
13. Tripartite-motif protein 21 knockdown extenuates LPS-triggered neurotoxicity by inhibiting microglial M1 polarization via suppressing NF-κB-mediated NLRP3 inflammasome activation.
Xiao T; Wan J; Qu H; Li Y
Arch Biochem Biophys; 2021 Jul; 706():108918. PubMed ID: 33992596
[TBL] [Abstract][Full Text] [Related]
14. The role of Nurr1-miR-30e-5p-NLRP3 axis in inflammation-mediated neurodegeneration: insights from mouse models and patients' studies in Parkinson's disease.
Li T; Tan X; Tian L; Jia C; Cheng C; Chen X; Wei M; Wang Y; Hu Y; Jia Q; Ni Y; Al-Nusaif M; Li S; Le W
J Neuroinflammation; 2023 Nov; 20(1):274. PubMed ID: 37990334
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.
Liu L; Zhou T; Li T; Liang Z; Luo X
Behav Brain Res; 2022 Aug; 431():113923. PubMed ID: 35550840
[TBL] [Abstract][Full Text] [Related]
16. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-374a-5p inhibits neuroinflammation in neonatal hypoxic-ischemic encephalopathy via regulating NLRP3 inflammasome targeted Smad6.
Chen Z; Hu Y; Lu R; Ge M; Zhang L
Life Sci; 2020 Jul; 252():117664. PubMed ID: 32304765
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA SNHG1 Promotes Neuroinflammation in Parkinson's Disease via Regulating miR-7/NLRP3 Pathway.
Cao B; Wang T; Qu Q; Kang T; Yang Q
Neuroscience; 2018 Sep; 388():118-127. PubMed ID: 30031125
[TBL] [Abstract][Full Text] [Related]
19. Benzyl isothiocyanate inhibits inflammasome activation in E. coli LPS-stimulated BV2 cells.
Lee CM; Lee DS; Jung WK; Yoo JS; Yim MJ; Choi YH; Park S; Seo SK; Choi JS; Lee YM; Park WS; Choi IW
Int J Mol Med; 2016 Sep; 38(3):912-8. PubMed ID: 27430883
[TBL] [Abstract][Full Text] [Related]
20. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.
Arioz BI; Tastan B; Tarakcioglu E; Tufekci KU; Olcum M; Ersoy N; Bagriyanik A; Genc K; Genc S
Front Immunol; 2019; 10():1511. PubMed ID: 31327964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
